Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2169540Generated: October 30, 2026

(S)-morpholine-3-carboxylic acid → (R)-2-chloro-5,6,6a,7,9,10-hexahydro-[1,4]oxazino[3,4-h]pteridine

https://huagongshe.com/reaction/2169540

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(S)-morpholine-3-carboxylic acidHCID 1501894—
ReactantHCID 86670087HCID 86670087—
SolventMethanolHCID 887—
Product(R)-2-chloro-5,6,6a,7,9,10-hexahydro-[1,4]oxazino[3,4-h]pteridineHCID 86670088—

Reaction Steps

An enantiomeric mixture of 2-chloro-5,6,6a,7,9,10-hexahydro-[1,4]oxazino[3,4-h]pteridine (PREPARATION x2, 8 g) was dissolved in MeOH (400 mL) and was separated by supercritical fluid chromatography (SFC) (Chiralcel® AS-H (5 μm, 20×150 mm), 20% MeOH in liquid CO2 at 55 mL/min, 3 mL/injection). The peak eluting at ˜5 minutes was collected. The stereo-configuration was assigned based on a comparison of retention times of an enantiomerically-enriched sample synthesized in a manner similar to PREPARATION x1 and PREPARATION x2 using optically pure (S)-morpholine-3-carboxylic acid.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09045496B2
Source datasetuspto-grants-2015_06
ORD IDord-b885ef779c5a4fc98e7cd39bd53eb96e
Source noteuspto-grants-2015_06